Lista de obras - Maria Jose Garcia - Dominio Público Uruguay

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes

artículo científico publicado en 2005

A Recurrent Chromosome Breakpoint in Breast Cancer at theNRG1/Neuregulin 1/HeregulinGene

article

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

artículo científico publicado en 2017

Analysis of DNA repair-related genes in breast cancer reveals CUL4A ubiquitin ligase as a novel biomarker of trabectedin response.

artículo científico publicado en 2013

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

article

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases

artículo científico publicado en 2013

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

artículo científico publicado en 2012

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2018

Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas

article

Chromosome pairing in the allotetraploid Aegilops biuncialis and a triploid intergeneric hybrid

artículo científico publicado en 1996

Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma

artículo científico publicado en 2002

Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.

artículo científico publicado en 2007

Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.

artículo científico publicado en 2009

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas.

artículo científico publicado en 2013

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.

artículo científico publicado en 2014

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells

artículo científico publicado en 2009

Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.

artículo científico publicado en 2008

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

artículo científico publicado en 2010

Genomic analysis of the 8p11-12 amplicon in familial breast cancer

article

Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines

artículo científico publicado en 2006

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

artículo científico publicado en 2014

Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas

article

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

IgH, TCR-γ, and TCR-β Gene Rearrangement in 80 B- and T-Cell Non-Hodgkin's Lymphomas: Study of the Association Between Proliferation and the So-called “Aberrant” Patterns

artículo científico publicado en 2001

Mutational analysis of FANCL , FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition

article

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

artículo científico publicado en 2018

The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.

artículo científico publicado en 2008

The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

artículo científico publicado en 2015

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

artículo científico publicado en 2006

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

artículo científico publicado en 2023

Lista de obras de Maria Jose Garcia

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes

A Recurrent Chromosome Breakpoint in Breast Cancer at theNRG1/Neuregulin 1/HeregulinGene

Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

Analysis of DNA repair-related genes in breast cancer reveals CUL4A ubiquitin ligase as a novel biomarker of trabectedin response.

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas

Chromosome pairing in the allotetraploid Aegilops biuncialis and a triploid intergeneric hybrid

Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma

Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.

Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas.

Deletion at 6q24.2-26 predicts longer survival of high-grade serous epithelial ovarian cancer patients.

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells

Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility.

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

Genomic analysis of the 8p11-12 amplicon in familial breast cancer

Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

IgH, TCR-γ, and TCR-β Gene Rearrangement in 80 B- and T-Cell Non-Hodgkin's Lymphomas: Study of the Association Between Proliferation and the So-called “Aberrant” Patterns

Mutational analysis of FANCL , FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.

The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study